Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

867
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
867
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.3K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.3K
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.2K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

824
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
824
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

661
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
661
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

450
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
450

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brief Review: Rethinking Colonic Redundancy in Gastroenterology.

Digestive diseases and sciencesยท2026
Same author

The Gut-Brain Axis-From Science to Clinical Practice.

Gastro hep advancesยท2026
Same author

Gastrointestinal Disorders in Scleroderma.

Gastroenterologyยท2026
Same author

Avoidant/Restrictive Food Intake Disorder in Disorders of Gut-Brain Interaction: Adaptive Restriction or Psychopathology?

Gastroenterologyยท2026
Same author

Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Are They Overdiagnosed?

Acta gastroenterologica Latinoamericanaยท2026
Same author

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of gut health.

Nature reviews. Gastroenterology & hepatologyยท2026

Related Experiment Video

Updated: Mar 9, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K

Primary Biliary Cirrhosis and the Microbiome.

Eamonn M M Quigley1

  • 1Division of Gastroenterology and Hepatology, Lynda K. and David M. Underwood Center for Digestive Disorders, Houston Methodist Hospital, Houston, Texas.

Seminars in Liver Disease
|December 21, 2016
PubMed
Summary

Primary biliary cirrhosis, a rare liver disease affecting women, may be initiated by gut bacteria. Further research is needed to understand the specific role of the microbiome in this autoimmune condition.

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Related Experiment Videos

Last Updated: Mar 9, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.4K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

Area of Science:

  • Hepatology
  • Microbiology
  • Autoimmune Diseases

Background:

  • Primary biliary cirrhosis (PBC) is a rare, progressive cholestatic liver disease primarily affecting middle-aged women.
  • While gut microbiome alterations are noted in liver diseases, their specific role in PBC remains largely unknown.
  • Existing evidence suggests a potential bacterial involvement in the autoimmune processes driving PBC pathogenesis.

Purpose of the Study:

  • To explore the current understanding of the gut microbiome's composition in primary biliary cirrhosis.
  • To investigate the potential role of bacterial species in the initiation of autoimmune responses in PBC.
  • To highlight the need for further research into the gut-liver axis in PBC.

Main Methods:

  • Review of epidemiological, clinical, and experimental data.
  • Analysis of existing literature on gut microbiome alterations in liver diseases.
  • Identification of studies suggesting bacterial involvement in PBC etiology.

Main Results:

  • The gut microbiome composition in PBC is not well-characterized.
  • A potential link exists between specific gut bacteria and the autoimmune mechanisms underlying PBC.
  • Further investigation is warranted to elucidate these microbial contributions.

Conclusions:

  • The gut microbiome is a potential factor in the initiation of primary biliary cirrhosis.
  • Understanding the specific bacteria involved could offer new insights into PBC pathogenesis.
  • Targeting the gut microbiome may represent a future therapeutic avenue for PBC.